Apellis Pharmaceuticals buy Sievi
Start price
08.08.23
/
50%
€22.40
Target price
08.09.23
-
Performance (%)
29.46%
End price
21.08.23
€29.00
Summary
This prediction ended on 21.08.23 with a price of €29.00. The prediction had a final performance of 29.46%. Sievi has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m | 1y |
---|---|---|---|
Apellis Pharmaceuticals | - | - | - |
iShares Core DAX® | 2.147% | 2.681% | 17.410% |
iShares Nasdaq 100 | -0.578% | -0.816% | 24.107% |
iShares Nikkei 225® | 0.635% | 3.079% | 16.921% |
iShares S&P 500 | 0.746% | 0.171% | 23.802% |
According to Sievi what are the pros and cons of Apellis Pharmaceuticals for the foreseeable future?
Pros
Could be very worthwhile Investment >20% year